Cellular and humoral immune responses and protection against schistosomes induced by a radiation-attenuated vaccine in chimpanzees

Infection and Immunity

Volumn 69, Issue 9, 2001, Pages 5352-5362

  Eberl, M ^a   Langermans, J A M ^a   Frost, P A ^a   Vervenne, R A ^a   Van Dam, G J ^a   Deelder, A M ^a   Thomas, A W ^a   Coulson, P S ^a   Wilson, R A ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA GLUTAMYLTRANSFERASE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; RECOMBINANT ANTIGEN; SCHISTOSOMA VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN DETECTION; ARTICLE; CELLULAR IMMUNITY; CHIMPANZEE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ACTIVITY; ENZYME ASSAY; EOSINOPHILIA; FECES ANALYSIS; HEMATOCRIT; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; LEUKOCYTOSIS; MALE; MORBIDITY; NONHUMAN; PRIORITY JOURNAL; PROTECTION; RADIATION ATTENUATION; SCHISTOSOMA MANSONI; VACCINATION;

ANIMALS; ANTIBODIES, HELMINTH; ANTIGENS, HELMINTH; CYTOKINES; IMMUNIZATION SCHEDULE; LYMPHOCYTE ACTIVATION; MALE; PAN TROGLODYTES; PARASITE EGG COUNT; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; TH1 CELLS; TH2 CELLS; VACCINATION; VACCINES, ATTENUATED;

EID: 0034861260     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.69.9.5352-5362.2001     Document Type: Article

References (70)

1. Hepatocellular carcinoma associated with chronic Schistosoma mansoni infection in a chimpanzee
2. Age-dependent reduction of schistosome fecundity in Schistosoma haematobium but not Schistosoma mansoni infections in humans
3. Protective immunity in baboons vaccinated with a recombinant antigen or radiation-attenuated cercariae of Schistosoma mansoni is antibody-dependent
4. Tests of the liver: Use and misuse
5. Evidence of a T helper type 2 activation in human schistosomiasis
6. The schistosome egg: Development and secretions
7. Schistosomiasis vaccines: Research to development
8. Longitudinal studies on human schistosomiasis
9. Immunity and morbidity in human schistosomiasis mansoni
10. Susceptibility and resistance to Schistosoma mansoni reinfection: Parallel cellular and isotypic immunologic assessment
11. Schistosomiasis: Forty years war on the worm
12. Apoptosis: A mechanism of immunoregulation during human schistosomiasis mansoni
13. Comparison of Th1- and Th2-associated immune reactivities stimulated by single versus multiple vaccination of mice with irradiated Schistosoma mansoni cercariae
14. Human schistosomiasis: Potential long-term consequences of vaccination programmes
15. The radiation-attenuated vaccine against schistosomes in animal models: Paradigm for a human vaccine?
16. The epidemiology of a recent focus of mixed Schistosoma haematobium and Schistosoma mansoni infections around the 'Lac de Guiers' in the Senegal River Basin, Senegal
17. Sensitive determination of circulating anodic antigen in Schistosoma mansoni infected individuals by an enzyme-linked immunosorbent assay using monoclonal antibodies
18. Detection of the schistosome circulating cathodic antigen by enzyme immunoassay using biotinylated monoclonal antibodies
19. Antigen-specific cellular hyporesponsiveness in a chronic human helminth infection is mediated by Th3/Tr1-type cytokines IL-10 transforming growth factor-beta but not by a Th1 to Th2 shift
20. Immunity after treatment of human schistosomiasis: Association between IgE antibodies to adult worm antigens and resistance to reinfection
21. Isolation of T cell antigens by using a recombinant protein library and its application to the identification of novel vaccine candidates against schistosomiasis
22. IL-18 potentiates the adjuvant properties of IL-12 in the induction of a strong Th1 type immune response against a recombinant antigen
23. Antibodies to glycans dominate the host response to schistosome larvae and eggs: Is their role protective or subversive?
24. The morbidity of schistosomiasis mansoni in Maniema (Zaire)
25. Schistosomiasis vaccines: A devils' advocate view
26. IgA antibodies to a protective antigen in human Schistosomiasis mansoni
27. Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium
28. Characterization, cloning and immunogenicity of antigens released by lung-stage larvae of Schistosoma mansoni
29. Characterization, cloning and immunogenicity of antigens released by transforming cercariae of Schistosoma mansoni
30. Immunization against Schistosoma japonicum in chimpanzees by administration of x-irradiated cercariae
31. Optimal vaccination against Schistosoma mansoni requires the induction of both B cell- and IFN-gamma-dependent effector mechanisms
32. Schistosoma mansoni-related morbidity on Ukerewe Island, Tanzania: Clinical, ultrasonographical and biochemical parameters
33. A calreticulin-like molecule from the human hookworm Necator americanus interacts with CIq and the cytoplasmic signalling domains of some integrins
34. Evaluation of Kato's quantitative method through the recovery of Schistosoma mansoni eggs added to human feces
35. Experimental infection with Schistosoma intercalatum (Fisher, 1934) in the chimpanzee (Pan troglodytes) and the gibbon (Hylobates lar)
36. Serum enzyme changes in calves experimentally infected with Schistosoma bovis
37. Cytokine regulation of human immune response to Schistosoma mansoni: Analysis of the role of IL-4, IL-5 and IL-10 on peripheral blood mononuclear cell responses
38. Serum enzyme tests in hepatosplenic schistosomiasis
39. Cellular immune responses of a Senegalese community recently exposed to Schistosoma mansoni: Correlations of infection level with age and inflammatory cytokine production by soluble egg antigen-specific cells
40. Increased interleukin-4 and interleukin-5 production in response to Schistosoma haematobium adult worm antigens correlates with lack of reinfection after treatment
41. Cytokine production in acute versus chronic human schistosomiasis mansoni: The cross-regulatory role of interferon-γ and intedeukin-10 in the responses of peripheral blood mononuclear cells and splenocytes to parasite antigens
42. A stage-specific calcium-binding protein expressed in eggs of Schistosoma mansoni
43. Antigens derived from lung-stage larvae of Schistosoma mansoni are efficient stimulators of proliferation and gamma interferon secretion by lymphocytes from mice vaccinated with irradiated cercariae
44. The contribution of hookworm and other parasitic infections to haemoglobin and iron status among children and adults in western Kenya
45. Maintaining the immunological balance in parasitic infections: A role for TGF-β?
46. Antibody to carbohydrate and polypeptide epitopes on the surface of schistosomula of Schistosoma mansoni in Egyptian patients with acute and chronic schistosomiasis
47. Downregulation of Th1 cytokine production accompanies induction of Th2 responses by a parasitic helminth. Schistosoma mansoni
48. T-helper type-1-dominated lymph node responses induced in C57BL/6 mice by optimally irradiated cercariae of Schistosoma mansoni are down-regulated after challenge infection
49. Relating serum circulating anodic antigens to faecal egg counts in Schistosoma mansoni infections: A modelling approach
50. Onchocerca volvulus: Immunization of chimpanzees with X-irradiated third-stage (L3) larvae
51. A natural case of Schistosoma mansoni in the chimpanzee (Pan troglodytes versus)
52. Use of attenuated sporozoites in the immunization of human volunteers against falciparum malaria
53. Immunity after treatment of human schistosomiasis: Association between cellular responses and resistance to reinfection
54. Characterization of the non-apparent clinical form in the initial phase of schistosomiasis mansoni
55. Schistosomiasis mansoni in the chimpanzee: Parasitologic, clinical, serologic, pathologic and radiologic observations
56. Experimental infection with Schistosoma haematobium in chimpanzees
57. Ablation of eosinophil and IgE responses with anti-IL-5 or anti-IL-4 antibodies fails to affect immunity against Schistosoma mansoni in the mouse
58. Monoclonal antibody to IFN-γ modifies pulmonary inflammatory responses and abrogates immunity to Schistosoma mansoni in mice vaccinated with attenuated cercariae
59. Immunoregulatory role of IL-10 during superantigen-induced hyporesponsiveness in vivo
60. Longitudinal study on the health status of children in a rural Tanzanian community: Parasitoses and nutrition following control measures against intestinal parasites
61. x-containing oligosaccharide attenuates schistosome egg antigen-induced immune depression in human schistosomiasis
62. Interferon-gamma production by peripheral blood mononuclear cells from residents of an area endemic for Schistosoma mansoni
63. Comparison of antibody isotype responses to Schistosoma mansoni antigens by infected and putative resistant individuals living in an endemic area
64. Experimental production of bilharzial pipe-stem fibrosis in the chimpanzee
65. Experimental infection with Schistosoma japonicum in chimpanzees
66. Leukocytes of patients with Schistosoma mansoni respond with a Th2 pattern of cytokine production to mitogen or egg antigens but with a Th0 pattern to worm antigens
67. Why don't we have a schistosomiasis vaccine?
68. Protection against Schistosoma mansoni and associated immune responses induced in the vervet monkey Cercopithecus aethiops by the irradiated cercaria vaccine
69. Protective immunity to Schistosoma mansoni induced in the olive baboon Papio anubis by the irradiated cercaria vaccine